Assessment of vitamin D oral supplementationon on insulin resistance, visceral fat and adiponectin in women with polycystic ovary syndrome and hypovitaminosis D
Phase 2
- Conditions
- Polycystic Ovary Syndrome.Sclerocystic ovary syndrome Stein-Leventhal syndrome
- Registration Number
- IRCT2016101030248N1
- Lead Sponsor
- Vice chancellor for research, Urmia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
Women with pcos according rotterdom criteria; Vitamin D deficiency ( x=<20 ng); OCPs consumer; Age between 20 to 38
Exclude criteria: Under 20 and over 38 years old; Neoplastic disorders; hepatic; renal; cardiovascular; malabsorptive and pregnancy; Those who consume vitamin D and taking antidiabetic drugs; People who follow a special diet pattern had specific physical activity
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: before intervention-after intervention (2 month later). Method of measurement: insulin resistance: HOMA-IR, HOMA-B ,QUICKI.;Visceral fat. Timepoint: before intervention-after intervention(2 month later). Method of measurement: visceral fat :BIA(Inbody 770).;Adiponectin. Timepoint: before intervention-after intervention(2 month later). Method of measurement: Adiponectin.: serum adiponectin.
- Secondary Outcome Measures
Name Time Method Sun exposure and physical activity. Timepoint: during intervention. Method of measurement: The questionnaire sunlight.;Diet. Timepoint: week 4-6-8. Method of measurement: 24-hour recalls.